Your browser doesn't support javascript.
loading
Increasing prevalence 2015-2019 of amyotrophic lateral sclerosis in Sardinia, Italy.
Pateri, Maria Ida; Pilotto, Silvy; Borghero, Giuseppe; Pili, Francesca; Pierri, Vincenzo; Ercoli, Tommaso; Gigante, Angelo Fabio; Muroni, Antonella; Defazio, Giovanni.
Afiliación
  • Pateri MI; Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.
  • Pilotto S; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Borghero G; Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy. pilottosilvy@gmail.com.
  • Pili F; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy. pilottosilvy@gmail.com.
  • Pierri V; Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.
  • Ercoli T; Institute of Neurology, University Hospital of Cagliari, Cagliari, Italy.
  • Gigante AF; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Muroni A; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Defazio G; Section of Neurology, San Paolo Hospital, Bari, Italy.
Neurol Sci ; 44(8): 2781-2786, 2023 Aug.
Article en En | MEDLINE | ID: mdl-36964314
ABSTRACT

BACKGROUND:

While amyotrophic lateral sclerosis (ALS) incidence has increased during the last decades, structured evidence on increased prevalence is lacking. After reporting a significant yearly increase of ALS incidence over a 10-year period, we checked for increased prevalence in Southern Sardinia over a quinquennium.

METHODS:

ALS patients (El Escorial Criteria) recruited from the study area and followed at ALS Centre, University of Cagliari, were included. Prevalence was computed for January 1, 2015 and January 1, 2019 and was calculated for the overall ALS population as well as for tracheostomized and non-tracheostomized patients.

RESULTS:

We observed a non-significant trend for greater ALS prevalence in 2019 than in 2015 (18.31 per 100,000 vs. 15.26 per 100,000; rate ratio 1.83, p = 0.01). By contrast, a significantly raising 2015 to 2019 ALS prevalence was observed in tracheostomized patients. No significant difference could be detected in non-tracheostomized.

CONCLUSIONS:

We provided the highest prevalence rate to date reported in the worldwide literature, and also showed a non-significant raising ALS prevalence in the Sardinian population over a quinquennium. The trend in raising ALS prevalence was likely due to extended survival due to invasive interventions.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Amiotrófica Lateral Tipo de estudio: Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Neurol Sci Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Esclerosis Amiotrófica Lateral Tipo de estudio: Incidence_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Límite: Humans País/Región como asunto: Europa Idioma: En Revista: Neurol Sci Asunto de la revista: NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: Italia